매사추세츠의 암 (전체) 임상 시험
암 (전체) 관련 연구 97개가 매사추세츠 내 여러 지역에서 참여자를 모집하고 있습니다.
매사추세츠의 도시
공식 연구 텍스트(영어)
A Study of ASP3082 in Adults With Advanced Solid Tumors
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Beth Israel Deaconess Medical Center - Research, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07192471A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Massachusetts General Hospital, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07578571uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05874921Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Baystate Medical Center, Springfield
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05256225A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT07127874A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06881992A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Dana Farber Cancer Center ( Site 4013), Boston
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07630974A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Reliant Medical Group Inc, Worcester
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT05920356A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Dana Farber/Harvard Cancer Center, Boston
- University of Massachusetts - UMass Chan Medical School, Worcester
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06901531Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
- Massachusetts General Hospital, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06910969Pan Tumor Rollover Study
- Dana_Farber Cancer Institute (DFCI), Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT03899155A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Dana-Farber Cancer Institute /ID# 279690, Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07365241Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
- Beth Israel Deaconess Medical Center ( Site 0107), Boston
- Dana-Farber Cancer Institute ( Site 0105), Boston
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07405164Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Dana Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06128551Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston
- University of Massachusetts Memorial Medical Center, North Worcester
피험자 모집 중2/3상
전 연령 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Dana-Farber Cancer Institute ( Site 3013), Boston
피험자 모집 중1/2상
1 Month – 17 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06941272Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
피험자 모집 중
18세 이하 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT06609473Statins to Prevent Cancer Associated Blood Clots
- Beth Isreal Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07303816ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
- Dana-Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07232043Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- VA Boston Jamaica Plains Campus, West Roxbury
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT05796375RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dana Farber Cancer Institute, Boston
- University of Massachusetts Chan Medical Center, Worcester
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07002034(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Dana-Farber Cancer Institute, Boston
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04996875A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Dana-Farber Cancer Institute /ID# 271846, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT06953960A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Dana-Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT05386108A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06253871A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Boston Medical Center, Boston
- Lahey Hospital & Medical Center, Burlington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Dana Farber Cancer Institute, Boston
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06163534Lurbinectedin in FET-Fused Tumors
- Dana-Farber Cancer Institute, Boston
피험자 모집 중1/2상
10세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05918640Prostate Active Surveillance Study
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
피험자 모집 중관찰 연구
21세 이상 · 남성 · 2026. 9. 2. 업데이트됨 · NCT00756665A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Massachusetts General Hospital (MG), Boston
피험자 모집 중1상
18세 ~ 99세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT06983743A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Massachusetts General Hospital, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07075185BRIDGE-SIC Efficacy Trial
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 8. 26. 업데이트됨 · NCT07735442Project: Every Child for Younger Patients With Cancer
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
- Baystate Medical Center, Springfield
- 외 1개
피험자 모집 중관찰 연구
25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Boston Medical Center, Boston
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05335928A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Massachusetts General Hospital, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04104776FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT05919264A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
- Beth Israel Deaconess Medical Center, Boston
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06759649A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Massachusetts General Hospital Cancer Center, Boston
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.